feed,title,long_url,short_url
SeekingAlpha,InVivo Therapeutics soars 15% on FDA acceptance of preclinical module for HDE submission,https://seekingalpha.com/news/3714779,
SeekingAlpha,On the hour,https://seekingalpha.com/news/3714778,
